(Q39116530)

9 September 2017

title

EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia (English)

1 reference

9 September 2017

1 reference

1 reference

Imen Kallel

1

1 reference

9 September 2017

Abdelmajid Khabir

2

1 reference

9 September 2017

Noureddine Boujelbene

3

1 reference

9 September 2017

Raoudha Abdennadher

4

1 reference

9 September 2017

Jamel Daoud

5

1 reference

9 September 2017

Mounir Frikha

6

1 reference

9 September 2017

Sami Aifa

7

1 reference

9 September 2017

Tahya Sallemi-Boudawara

8

1 reference

9 September 2017

Ahmed Rebaï

9

1 reference

9 September 2017

publication date

6 March 2012

1 reference

Journal of Receptors and Signal Transduction

9 September 2017

published in

1 reference

9 September 2017

volume

32

1 reference

9 September 2017

issue

3

1 reference

9 September 2017

page(s)

142-149

1 reference

Untangling the ErbB signalling network

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

The role of EGFR-directed therapy in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Prognostic relevance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Estrogen receptor-alpha and C-ERBB-4 expression in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Estrogen-receptor biology: continuing progress and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Prognostic value of ERBB family mRNA expression in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Triple negative breast cancer: clinicopathological characteristics and treatment strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

What is triple-negative breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2012.664552

10.3109/10799893.2012.664552

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference